The Aptus Endosystems management team includes:
Jeff Elkins, Chief Executive Officer
Lee Bolduc, Vice President of Engineering, CTO, Co-Founder
Jeff Elkins, Chief Executive Officer
Jeff joined Aptus Endosystems from FlowMedica, a commercial stage company focused on endovascular treatments for acute kidney injury, where he was Chief Executive Officer until the company's acquisition by AngioDynamics (NASDAQ: ANGO). Prior to this, Jeff held various positions within Medtronic Vascular's Endovascular Unit, including Business Unit Manager, Vice President of R&D and Vice President of Business Development. During his tenure at Medtronic, Jeff oversaw operations pertaining to the TALENT and ANEURX AAA & TAA Endograft platforms, including the successful commercial launches of both product lines in both the U.S. and internationally. Jeff joined Medtronic via the acquisition of World Medical, the company that originally developed the TALENT AAA platform, where he was Vice President of Operations and Chief Technical Officer. Jeff joined World Medical after a series of operating and R&D roles at Cordis Endovascular Systems, Cordis Corporation and Haemonetics. He holds a BS in Mechanical Engineering from the University of Massachusetts, Amherst.
Lee Bolduc, Vice President of Engineering, CTO, Co-Founder
Prior to co-founding Aptus Endosystems, Mr. Bolduc was Vice President of Engineering at Salient Interventional Systems, where he led the engineering effort in the development of a catheter-based neuroperfusion system, bringing the project from concept to a successful OUS clinical study within one year. Prior to joining Salient, Mr. Bolduc was a Director of Engineering at Heartport, a venture financed medical technology company that helped to pioneer the field of minimally invasive cardio-thoracic surgery. At Heartport he led the automated anastomosis and beating heart programs prior to the company's acquisition by Johnson & Johnson.
Mr. Bolduc previously held positions in engineering and development at Origin MedSystems, (acquired by Guidant), designing and developing laparoscopic instruments, and at Omni-Trac Surgical, where he designed and developed surgical instruments and retractor systems. Mr. Bolduc has 16 years of experience in the medical device industry, is listed as an inventor on 61 issued United States patents and holds a B.S. Degree in Mechanical Engineering.
David H. Deaton, M.D., Consultant Medical Officer
David Deaton is Chief of Endovascular Surgery and Associate Professor of Surgery at Georgetown University Hospital in Washington, D.C.. Dr. Deaton has over 15 years experience in the practice vascular surgery. He was an original principle investigator in the earliest endovascular aneurysm repair device trials and has continued to participate in numerous vascular and endovascular device developments and clinical trials over the past 10 years of his clinical practice, with particular interest in aortic, carotid and lower extremity diseases.
Dr. Deaton is a graduate of Duke University School of Medicine. He completed his internship and surgical residency at the Hospital of the University of Pennsylvania and his fellowship at the University of California, Los Angeles. He is board certified in both surgery and vascular surgery and is an active member of the Society for Vascular Surgery and the Peripheral Vascular Surgery Society.